secwatch.observer — SEC 8-K summary
======================================

Issuer:     Skye Bioscience, Inc. (SKYE)
CIK:        0001516551
Form:       8-K/A
Filed at:   2023-03-27T23:59:59+00:00
Accession:  0001516551-23-000034
Event type: leadership
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Skye Bioscience appoints Director Deborah Charych to Nominating and Corporate Governance Committee
--------------------------------------------------------------------------------

- On March 21, 2023, Board appointed Dr. Deborah Charych to the Nominating and Corporate Governance Committee, effective immediately.
- Amendment to Feb 16, 2023 8-K that reported Dr. Charych's appointment as director.
- No other changes to committee assignments or board composition.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1516551/000151655123000034/0001516551-23-000034-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1516551/000151655123000034/skye-20230214.htm
  HTML page:      https://secwatch.observer/filing/0001516551-23-000034

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer